Tenapanor Reduces Elevated Serum Phosphate in CKD
FRIDAY, March 8, 2019 -- For hyperphosphatemic patients with chronic kidney disease receiving maintenance hemodialysis, tenapanor significantly reduces elevated serum phosphate, according to a study published online March 7 in the Journal of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Chronic Kidney Disease | Dialysis | Hemodialysis | Pharmaceuticals | Study | Urology & Nephrology